CIM
RMD icon

CCLA Investment Management’s ResMed RMD Stock Holding History

CCLA Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,316
Closed -$5.43M – 68
2024
Q3 		$5.43M Hold
28,316
– – 0.08% 60
2024
Q2 		$5.43M Buy
28,316
+830
+3% +$168K 0.08% 60
2024
Q1 		$5.43M Buy
27,486
+4,779
+21% +$876K 0.08% 61
2023
Q4 		$3.91M Buy
22,707
+627
+3% +$96.3K 0.06% 63
2023
Q3 		$3.28M Hold
22,080
– – 0.06% 65
2023
Q2 		$4.82M Buy
22,080
+295
+1% +$65.7K 0.09% 64
2023
Q1 		$4.75M Hold
21,785
– – 0.09% 65
2022
Q4 		$4.53M Buy
21,785
+99
+0.5% +$21.8K 0.1% 62
2022
Q3 		$4.74M Buy
+21,686
New +$4.94M 0.11% 63
2022
Q1 		$5.19M Buy
21,408
+7,915
+59% +$1.91M 0.09% 64
2021
Q4 		$3.52M Buy
+13,493
New +$3.5M 0.06% 63

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CCLA Investment Management's RMD Position: Q4 2024 in Review

CCLA Investment Management sold out of ResMed (RMD) in Q4 2024, closing a stake of 28,316 shares — an estimated $5.43M sold.

CCLA Investment Management first reported a position in RMD in Q4 2021 and held it in 11 quarters. The position peaked at $5.43M in Q1 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • CCLA Investment Management reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • CCLA Investment Management sold 28,316 ResMed shares in Q4 2024, an estimated $5.43M.
  • CCLA Investment Management first reported a position in ResMed in Q4 2021 and held it in 11 quarters.
  • CCLA Investment Management's ResMed position peaked at $5.43M in Q1 2024.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on CCLA Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.